
Peer-Reviewed Research Shows CGM Benefits Through Medical Over Pharmacy
Key Highlights
- 35% lower total care costs for CGM patients using medical benefits over pharmacy.
- 23% higher adherence to CGM therapy through medical benefit.
- CCS presented findings at ADCES and ISPOR conferences.
- AI-powered PropheSee™ model boosts patient adherence by up to 50%.
Source: Business Wire
Notable Quotes
“ CGMs are only effective if people use them. This first-of-its-kind research demonstrates that a physician’s decision to direct a patient to use their medical benefit instead of their pharmacy benefit when accessing a medical device can seriously impact health outcomes and costs of care. ”
Dr. Arti Masturzo, Chief Medical Officer at CCS
“ They’ve coached me on how to use a CGM and helped educate me on the value of using my medical benefit. ”
Scott Gerberich, Patient
SoHC's Take
The research from CCS underscores the importance of ensuring that patients access continuous glucose monitoring (CGM) devices through their medical benefits instead of pharmacy benefits. The data-driven insights highlight significant cost savings and improved adherence, which are crucial for both patient outcomes and healthcare sustainability. CCS’s integration of education, coaching, and AI-driven predictive tools further cements its role as a leader in chronic care management, particularly for diabetes care. With rising CGM adoption and an urgent need for effective patient support, CCS’s innovations, like PropheSee™, offer a promising model for the future of proactive chronic care management.
Heading
Ginkgo Bioworks Launches Protein LLM and Model API Powered by Google Cloud News Product News Read More Chris-Anne Roque Peer-Reviewed Research Shows CGM Benefits Through Medical Over Pharmacy Clinical News News Read More Chris-Anne Roque Mirador Therapeutics Appoints Gregg Gilbert as CFO to Drive Growth Hiring News News Read More Chris-Anne Roque Entact Bio Appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer Hiring News News Read More Chris-Anne Roque #467 – Dr. Jason Stein, Chief Medical Officer at Ingenious Med AI Healthcare Innovation Read More Windley Mathurin BioDuro-Sundia Appoints Dr. Armin Spura as New CEO Hiring News News Read More Chris-Anne Roque